TrivarX

TrivarX ROCE

The Return on Capital Employed (ROCE) of TrivarX (TRI.AX) as of Oct 28, 2026 is -52.74 %. In the previous year, Return on Capital Employed (ROCE) was -16.11 % — a change of 227.33% (lower).

ROCE

-52.74 %

YoY

227.33%

Last updated:

In 2026, TrivarX's return on capital employed (ROCE) was -52.74 %, a 227.33% increase from the -16.11 % ROCE in the previous year.

The TrivarX ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2019
-76.39 AUD
Jan 1, 2020
-30.42 AUD
Jan 1, 2021
-16.05 AUD
Jan 1, 2022
-51.20 AUD
Jan 1, 2023
-50.68 AUD
Jan 1, 2024
-24.05 AUD
Jan 1, 2025
-16.11 AUD
Jan 1, 2026
-52.74 AUD
The TrivarX ROCE history
YEARROCEYoY
-52.74 %+227.33%
-16.11 %-33.00%
-24.05 %-52.55%
-50.68 %-1.02%
-51.20 %+219.03%
-16.05 %-47.24%
-30.42 %-60.18%
-76.39 %-42.83%
-133.61 %+86.90%
-71.49 %-16.78%
-85.91 %+110.58%
-40.80 %+39.73%
-29.20 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

TrivarX Stock analysis

What does TrivarX do? TrivarX Ltd generates revenue through its corporate health product, which provides mental well-being solutions for businesses. The company develops and commercializes mental health technology using objective biomarkers for screening, diagnosing, monitoring, and managing depression. Its consumer mobile application LUCA offers biometric assessments measuring sleep stress, activity stress, and cardiac stress, enabling users to monitor stress levels via personal wearable devices. The company focuses on early detection and screening of mental health conditions through clinical research and product development. The primary buyers of TrivarX's corporate health product are businesses seeking mental well-being solutions for their employees. The consumer application LUCA targets individuals interested in monitoring their stress levels using wearable technology. TrivarX's technology is designed to assist in the early detection and screening of mental health conditions, with a focus on depression management through objective biomarker analysis. The company's clinical research and product development activities support both business and consumer segments in the mental health technology market. TrivarX is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling TrivarX's Return on Capital Employed (ROCE)

TrivarX's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing TrivarX's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

TrivarX's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in TrivarX’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about TrivarX stock

Return on Capital Employed (ROCE) of TrivarX is -52.74 % in 2026.

Return on Capital Employed (ROCE) of TrivarX changed from -16.11 % to -52.74 %, representing a 227.33% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) TrivarX since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s TrivarX with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — TrivarX

All Key Metrics — TrivarX